Evidence for imaging-based diagnosis of liver metastases from colorectal cancer
- 22 August 2025
- journal article
- review article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 60 (12) , 1471-1480
Abstract
Metastatic liver tumors are more common than primary liver cancers and are the most common liver malignancies. Performing B-mode ultrasonography and contrast-enhanced computed tomography is generally necessary for the diagnosis of liver metastases. However, various modalities, including dynamic contrast-enhanced computed tomography and magnetic resonance imaging using liver-specific contrast agents such as gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid, fluorodeoxyglucose positron emission tomography, and a combination of positron emission tomography and computed tomography, are also used. Improvements in imaging technology have made the detection of small liver masses possible, and liver metastases are being diagnosed more frequently, both before and after primary tumor treatment. The diagnosis of liver metastasis is related to treatment, and the benefits of liver resection depend on the primary tumor. For colorectal cancer, resection of liver metastases is beneficial. However, resection is not recommended for pancreatic or biliary tract cancers.Keywords
This publication has 43 references indexed in Scilit:
- MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastasesAbdominal Radiology, 2018
- Assessment of Therapy Response to Transarterial Radioembolization for Liver Metastases by Means of Post-treatment MRI-Based Texture AnalysisCardioVascular and Interventional Radiology, 2018
- Diagnostic performance of CT, gadoxetate disodium‐enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta‐analysisJournal of Magnetic Resonance Imaging, 2017
- Comparison of contrast‐enhanced ultrasonograpy with Gd‐EOB‐DTPA‐enhanced MRI in the diagnosis of liver metastasis from colorectal cancerJournal of Clinical Ultrasound, 2016
- Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?European Radiology, 2014
- Randomized multicentre trial of gadoxetic acid-enhanced MRIversusconventional MRI or CT in the staging of colorectal cancer liver metastasesBritish Journal of Surgery, 2014
- Diagnosis of colorectal hepatic metastases: Comparison of contrast‐enhanced CT, contrast‐enhanced US, superparamagnetic iron oxide‐enhanced MRI, and gadoxetic acid‐enhanced MRIJournal of Magnetic Resonance Imaging, 2011
- Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinomaEuropean Radiology, 2011
- Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patientsEuropean Radiology, 2010
- Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysisJournal of Magnetic Resonance Imaging, 2009